Skip to main content

Support and resources for you and your patients

ELAHERE Videos ELAHERE Videos Eye Care Videos Patient Testimonials Access & Assistance Access & Assistance Resource Library ELAHERE Videos FAQs

ELAHERE videos

Learn about ELAHERE from experts

Hear fellow healthcare professionals talk about various topics relevant to platinum-resistant ovarian cancer (PROC) and treatment with ELAHERE.

Platinum-Resistant Ovarian Cancer: A Patient Case Discussion

Watch a consultation between medical oncologist Dr Martin Dietrich and gynecologic oncologist Dr Robert Holloway regarding a patient with FRα-positive* PROC and how ELAHERE may be able to help

Starting Patients on a Targeted Treatment for Platinum-Resistant Ovarian Cancer

Watch medical oncologist Dr Martin Dietrich and gynecologic oncologist Dr Robert Holloway discuss key steps for starting patients on ELAHERE, including dosing and administration, proactive management of ocular adverse reactions, and available support and resources

Platinum Resistance in Ovarian Cancer

Watch gynecologic oncologist Dr Kristin Taylor discuss perspectives on platinum-resistant ovarian cancer, how it affects treatment, and ELAHERE as an option

FRα 101: What It Is and Why It Matters

Watch gynecologic oncologist Dr Mark Shahin explain the significance of FRα in ovarian cancer, how testing is performed, and determining eligibility for ELAHERE

How an ADC Works in Platinum- Resistant Ovarian Cancer

Watch gynecologic oncologist Dr Kristin Taylor discuss what antibody-drug conjugates (ADCs) are, how they can provide targeted treatment in PROC, and how ELAHERE works

*FRα positive is defined as ≥75% of viable tumor cells with moderate (2+) and/or strong (3+) membrane staining based on an IHC assay.1

 FRα=folate receptor alpha; IHC=immunohistochemistry.

Videos about management of ocular adverse reactions while on ELAHERE

Learn more about eye care for patients on ELAHERE, from how to effectively work with care teams to helping patients understand what they can expect while on treatment.

Eye Care Provider Best Practices

See an overview of ELAHERE treatment and the important role eye care providers play in helping to proactively manage ocular adverse reactions, as well as best practices and available resources

What Patients Can Expect at Eye Care Exams

Watch Dr Kristen Lamoreau discuss partnering with an eye care provider and steps you and your patients can take to help proactively manage ocular adverse reactions

Stories from real ELAHERE patients

Watch these videos from real people with FRα-positive PROC who were prescribed ELAHERE, and share with your patients to help them through their own journeys.

Heidi's Story

Meet Heidi, a real patient who was prescribed ELAHERE. In this video, Heidi shares her personal experiences navigating ovarian cancer, building a support system, and receiving treatment with ELAHERE

Cindy's Story

Meet Cindy, a real patient who was prescribed ELAHERE. In this video, Cindy shares her personal experiences with ELAHERE treatment and how it has impacted her life

Connect with a rep

Have questions about ELAHERE?
Contact a representative
for help and updates.
REQUEST A REP

Enroll your patients

Fill out the ELAHERE Support Services Patient
Enrollment Form to help your patients get the support
they need when starting treatment.
DOWNLOAD FORM
  1. VENTANA FOLR1 (FOLR1-2.1) RxDx Assay. Package insert. Roche; 2022.